Donglin Luo

1.4k total citations · 1 hit paper
38 papers, 965 citations indexed

About

Donglin Luo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Donglin Luo has authored 38 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Donglin Luo's work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (4 papers). Donglin Luo is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (4 papers). Donglin Luo collaborates with scholars based in China, Canada and United States. Donglin Luo's co-authors include Wei Xing, Xiang Xu, Wuguo Tian, Bo Gao, Wei Guo, Xiang Ao, Zhan Li, Luoquan Ao, Xueting Hu and Quan Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and British Journal of Pharmacology.

In The Last Decade

Donglin Luo

33 papers receiving 958 citations

Hit Papers

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donglin Luo China 17 599 410 168 128 88 38 965
Shengping Huang United States 17 585 1.0× 218 0.5× 262 1.6× 130 1.0× 136 1.5× 31 1.2k
Linda Pestano United States 14 694 1.2× 483 1.2× 71 0.4× 45 0.4× 59 0.7× 25 990
Xiao He China 18 404 0.7× 236 0.6× 134 0.8× 102 0.8× 27 0.3× 44 818
Chee Ren Ivan Lam Singapore 9 241 0.4× 280 0.7× 125 0.7× 74 0.6× 28 0.3× 9 703
Jinming Tang China 15 350 0.6× 211 0.5× 55 0.3× 82 0.6× 199 2.3× 35 720
Sohel M. Julovi Australia 17 217 0.4× 182 0.4× 104 0.6× 140 1.1× 33 0.4× 34 873
Wenchang Lv China 16 546 0.9× 353 0.9× 139 0.8× 79 0.6× 64 0.7× 34 869
Li Xiao China 15 567 0.9× 283 0.7× 87 0.5× 53 0.4× 130 1.5× 43 922
Ida Katrine Lund Denmark 18 335 0.6× 356 0.9× 264 1.6× 83 0.6× 13 0.1× 43 839
Francisco Caiado Portugal 17 501 0.8× 172 0.4× 206 1.2× 70 0.5× 39 0.4× 27 1.0k

Countries citing papers authored by Donglin Luo

Since Specialization
Citations

This map shows the geographic impact of Donglin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglin Luo more than expected).

Fields of papers citing papers by Donglin Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donglin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglin Luo. The network helps show where Donglin Luo may publish in the future.

Co-authorship network of co-authors of Donglin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Donglin Luo. A scholar is included among the top collaborators of Donglin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donglin Luo. Donglin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Changzi, et al.. (2025). A novel stochastic model updating method for offshore platforms based on Kriging model with active learning. Ocean Engineering. 340. 122330–122330.
2.
Zhang, Bingling, Donglin Luo, Lan Xiang, Jun Chen, & Ting Fang. (2024). Investigating the anti-cancer potential of sulfatase 1 and its underlying mechanism in non-small cell lung cancer. CytoJournal. 21. 52–52.
3.
Luo, Donglin, Jie Luo, Hong‐Qing Liang, et al.. (2023). [Efficacy and safety of peginterferon-α2b for treatment of myeloproliterative neoplasms].. PubMed. 43(6). 1029–1034.
4.
5.
Luo, Donglin, et al.. (2023). Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials. Open Life Sciences. 18(1). 20220668–20220668. 5 indexed citations
6.
Wan, Weijun, Xiang Ao, Quan Chen, et al.. (2022). METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Molecular Cancer. 21(1). 60–60. 276 indexed citations breakdown →
7.
Wang, Lingli, et al.. (2022). Analysis and prediction model of ferroptosis related genes in breast cancer. Translational Cancer Research. 11(7). 1970–1976. 6 indexed citations
8.
Wu, Jian, Donglin Luo, & Shuai Li. (2020). Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer. SHILAP Revista de lepidopterología. 4 indexed citations
9.
Guo, Wei, Wei Qiu, Xiang Ao, et al.. (2020). Low‐concentration DMSO accelerates skin wound healing by Akt/mTOR‐mediated cell proliferation and migration in diabetic mice. British Journal of Pharmacology. 177(14). 3327–3341. 28 indexed citations
10.
Tian, Wuguo, Shuai Hao, Bo Gao, et al.. (2018). Lobaplatin inhibits breast cancer progression, cell proliferation while induces cell apoptosis by downregulating MTDH expression. Drug Design Development and Therapy. Volume 12. 3563–3571. 13 indexed citations
11.
Guo, Lingji, Shu Zhang, Bo Gao, et al.. (2017). Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer. Experimental and Molecular Pathology. 102(3). 500–504. 35 indexed citations
12.
Chen, Yi, Donglin Luo, Wuguo Tian, Zhirong Li, & Xiaohua Zhang. (2017). Demethylation of miR-495 inhibits cell proliferation, migration and promotes apoptosis by targeting STAT-3 in breast cancer. Oncology Reports. 37(6). 3581–3589. 35 indexed citations
13.
Long, Ziwen, et al.. (2017). Short-term efficacy of different chemotherapy regimens in the treatment of advanced gastric cancer: a network meta-analysis. Oncotarget. 8(23). 37896–37911. 9 indexed citations
14.
Zhang, Shu, Lingji Guo, Gang Zhang, et al.. (2016). Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus. Tumor Biology. 37(8). 11057–11063. 20 indexed citations
15.
He, Yujun, et al.. (2014). Primary malignant melanoma of the breast: A case report and review of the literature. Oncology Letters. 8(1). 238–240. 20 indexed citations
16.
Chai, Jin, Donglin Luo, Xiaoping Wu, et al.. (2011). Changes of Organic Anion Transporter MRP4 and Related Nuclear Receptors in Human Obstructive Cholestasis. Journal of Gastrointestinal Surgery. 15(6). 996–1004. 38 indexed citations
17.
Chen, Zhendong, Zhimin Huang, Xiaosong Ben, et al.. (2011). Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma. Diseases of the Esophagus. 25(7). 664–670. 32 indexed citations
18.
Wang, Zhenxiang, et al.. (2011). Polyacrylamide Hydrogel Injection for Augmentation Mammaplasty. Annals of Plastic Surgery. 69(2). 123–128. 19 indexed citations
19.
Luo, Donglin, Xiankai Huang, Baohua Liu, et al.. (2010). Role of glucocorticoid receptor and nuclear factor kappa B in rat hepatic injury after traumatic hemorrhagic shock. African Journal of Pharmacy and Pharmacology. 4(12). 865–873. 2 indexed citations
20.
Luo, Donglin, et al.. (1996). Construction and Expression of Bi-Functional Proteins of Single-Chain Fv With Effector Domains. The Journal of Biochemistry. 120(2). 229–232. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026